Jean-Mathieu Beauregard

All papers authored by Jean-Mathieu Beauregard

This paper is made freely available by the publisher.

2021 Andreas Hallqvist

, Johanna Svensson, Linn Hagmarker, Ida Marin, Tobias Rydén, Jean-Mathieu Beauregard

, Peter Bernhardt

Optimizing the Schedule of PARP Inhibitors in Combination with 177Lu-DOTATATE: A Dosimetry Rationale

Download from doi.org

Rashmi G. Shah

, Marine A. Merlin, Samuel Adant, Fayçal Zine-Eddine, Jean-Mathieu Beauregard

, Girish M. Shah

Chemotherapy-Induced Upregulation of Somatostatin Receptor-2 Increases the Uptake and Efficacy of 177Lu-DOTA-Octreotate in Neuroendocrine Tumor Cells

Download from doi.org

2020 Alessandro Desy, Guillaume F. Bouvet, Andrea Frezza, Philippe Després, Jean-Mathieu Beauregard

Impact of dead time on quantitative 177Lu-SPECT (QSPECT) and kidney dosimetry during PRRT

Download from doi.org

Andrea Frezza, Corentin Desport, Carlos Uribe, Wei Zhao, Anna Celler, Philippe Després, Jean-Mathieu Beauregard

Comprehensive SPECT/CT system characterization and calibration for 177Lu quantitative SPECT (QSPECT) with dead-time correction

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

Salma Meziou, Salma Meizou, Cassandra Ringuette Goulet, Hélène Hovington, Véronique Lefebvre, Étienne Lavallée, Michelle Bergeron, Hervé Brisson, Audrey Champagne

, Bertrand Neveu, Didier Lacombe, Jean-Mathieu Beauregard

, François-Alexandre Buteau, Julie Riopel, Frédéric Pouliot

GLUT1 expression in high-risk prostate cancer: correlation with 18F-FDG-PET/CT and clinical outcome

Upload

2019 Etienne Lavallée, Michelle Bergeron, François-Alexandre Buteau, Annie-Claude Blouin, Nicolas Duchesnay, Thierry Dujardin, Rabi Tiguert, Louis Lacombe, Vincent Fradet, Molière Makao-Nguile, Yves Fradet, Jean-Mathieu Beauregard

, Frédéric Pouliot

Increased Prostate Cancer Glucose Metabolism Detected by 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Localised Gleason 8–10 Prostate Cancers Identifies Very High–risk Patients for Early Recurrence and Resistance to Castration

Upload

Samuel Adant, Girish M. Shah

, Jean-Mathieu Beauregard

Combination treatments to enhance peptide receptor radionuclide therapy of neuroendocrine tumours

Download from link.springer.com

Xinchi Hou, Wei Zhao

, Jean-Mathieu Beauregard

, Anna Celler

Personalized kidney dosimetry in 177Lu-octreotate treatment of neuroendocrine tumours: a comparison of kidney dosimetry estimates based on a whole organ and small volume segmentations

Upload

Wei Zhao

, Pedro Luis Esquinas

, Andrea Frezza, Xinchi Hou, Jean-Mathieu Beauregard

, Anna Celler

Accuracy of kidney dosimetry performed using simplified time activity curve modelling methods: a 177Lu-DOTATATE patient study

Upload

2018 Michela Del Prete, François-Alexandre Buteau, Frédéric Arsenault, Nassim Saighi, Louis-Olivier Bouchard, Alexis Beaulieu, Jean-Mathieu Beauregard

Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: initial results from the P-PRRT trial

Upload

Michela Del Prete, Frédéric Arsenault, Nassim Saighi, Wei Zhao, François-Alexandre Buteau, Anna Celler, Jean-Mathieu Beauregard

Accuracy and reproducibility of simplified QSPECT dosimetry for personalized 177Lu-octreotate PRRT

Download from doi.org

Frédéric Arsenault, Jean-Mathieu Beauregard

, Frédéric Pouliot

Prostate-specific membrane antigen for prostate cancer theranostics: from imaging to targeted therapy

Upload

Wei Zhao

, Pedro L. Esquinas, Xinchi Hou, Carlos F. Uribe, Marjorie Gonzalez, Jean-Mathieu Beauregard

, Yuni K. Dewaraja, Anna Celler

Determination of gamma camera calibration factors for quantitation of therapeutic radioisotopes

Download from doi.org

Nupur K. Purohit, Rashmi G. Shah

, Samuel Adant, Michael Hoepfner, Girish M. Shah, Jean-Mathieu Beauregard

Potentiation of ¹⁷⁷Lu-octreotate peptide receptor radionuclide therapy of human neuroendocrine tumor cells by PARP inhibitor

Download from doi.org

Julia R. Schneider, Deborah R. Shatzkes, Stephen C. Scharf, Tristan M. Tham, Kay O. Kulason, François-Alexandre Buteau, Michela Del Prete, Shamik Chakraborty, Todd A. Anderson, Saeed Asiry, Jean-Mathieu Beauregard

, David J. Langer, Peter D. Costantino, John A. Boockvar

Neuroradiological and Neuropathological Changes After 177Lu-Octreotate Peptide Receptor Radionuclide Therapy of Refractory Esthesioneuroblastoma

Upload

2017 Romain Espagnet

, Andrea Frezza, Jean-Pierre Martin, Louis-André Hamel, Laëtitia Lechippey, Jean-Mathieu Beauregard

, Philippe Després

A CZT-based blood counter for quantitative molecular imaging

Download from doi.org

Michela Del Prete

, François-Alexandre Buteau, Jean-Mathieu Beauregard

Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: a simulation study

Upload

Fannie Morin, Jean-Mathieu Beauregard

, Michelle Bergeron, Molière Nguile Makao, Louis Lacombe, Vincent Fradet

, Yves Fradet, Frédéric Pouliot

Metabolic Imaging of Prostate Cancer Reveals Intrapatient Intermetastasis Response Heterogeneity to Systemic Therapy

Download from doi.org

Uribe Cf, Carlos F. Uribe, Pedro L. Esquinas, Esquinas Pl, Jesse Tanguay, Marjorie Gonzalez, Emilie Gaudin, Jean-Mathieu Beauregard

, Beauregard Jm, Anna Celler

Accuracy of 177Lu activity quantification in SPECT imaging: a phantom study

Download from doi.org

2016 Jean-Mathieu Beauregard

, Alexis Beaulieu

How we read FCH-PET/CT for prostate cancer

Download from doi.org

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

All papers authored by Jean-Mathieu Beauregard